4D-Nucleofector® Platform

The Nucleofector^® Technology, introduced to the market by legacy Amaxa in 2001, uses a specific combination of optimized electrical parameters and cell type-specific solutions, which enables transfer of a molecule directly into the cell’s nucleus. Thus, Nucleofection^® is independent from cell proliferation and allows the transfection of non-dividing primary cells (e.g. resting T cells or neurons).

The advanced, flexible and convenient 4D-Nucleofector^® System comprises a Core Unit, as well as several functional units with different transfection capabilities to suit different applications.